A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma. [electronic resource]
Producer: 20151008Description: 297-303 p. digitalISSN:- 1527-3792
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Carcinoma, Renal Cell -- diagnosis
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Glomerular Filtration Rate -- drug effects
- Humans
- Indazoles
- Kidney -- diagnostic imaging
- Kidney Neoplasms -- diagnosis
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Nephrectomy -- methods
- Organ Size
- Prospective Studies
- Pyrimidines -- administration & dosage
- Retrospective Studies
- Sulfonamides -- administration & dosage
- Tomography, X-Ray Computed
- Treatment Outcome
- Tumor Burden
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.